Cart
sales@molnova.com
Bucillamine
CAS No. 65002-17-7
Bucillamine( DE-019 | DE 019 | DE019 | SA96 | Thiobutarit | Tiobutarit | )
Catalog No. M27391 CAS No. 65002-17-7
Bucillamine protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 31 | In Stock |
|
| 50MG | 52 | In Stock |
|
| 100MG | 86 | In Stock |
|
| 200MG | 127 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBucillamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBucillamine protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF.
-
DescriptionBucillamine protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF. Bucillamine is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. Bucillamine can be used for studies about choroidal neovascularization and rheumatoid arthritis.(In Vivo):In rats subjected to liver transplants, Bucillamine significantly enhances survival and protected against hepatic injury. Subconjunctival injection of Bucillamine significantly reduces the leakage and size of experimental CNV in rats.
-
In Vitro——
-
In VivoBucillamine significantly enhances survival and protected against hepatic injury in rats subjected to liver transplants.Bucillamine (Subconjunctival injection) significantly reduces the leakage and size of experimental CNV in rats.
-
SynonymsDE-019 | DE 019 | DE019 | SA96 | Thiobutarit | Tiobutarit |
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65002-17-7
-
Formula Weight223.31
-
Molecular FormulaC7H13NO3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 5 mg/mL (22.39 mM)
-
SMILESCC(C)(S)C(=O)NC(CS)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bevacizumab
Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
-
TG 100801
TG 100801 is a dual inhibitor of VEGFr2 and Src family (Src and YES) kinases and is a candidate compound for the treatment of age-related macular degeneration (AMD).
-
Anemoside A3
Anemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
